PFP
IBB icon

Polaris Financial Partners’s iShares Biotechnology ETF IBB Stock Holding History

Polaris Financial Partners’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$7K Buy
+34
New +$6.82K ﹤0.01% 297

Other funds holding IBB

MAM
Marotta Asset Management Charlottesville, Virginia $589M AUM 14.57% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
GA
GoalVest Advisory New York $578M AUM 17.41% 1-Year Est. Return

Polaris Financial Partners's IBB Position: Q3 2026 in Review

Polaris Financial Partners opened a new position in iShares Biotechnology ETF (IBB) in Q3 2026: 34 shares worth $7K. The stake represents ﹤0.01% of the portfolio and ranks #297 among its holdings.

5 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • Polaris Financial Partners held 34 shares of iShares Biotechnology ETF worth $7K as of Q3 2026.
  • iShares Biotechnology ETF was a new Polaris Financial Partners position in Q3 2026.
  • iShares Biotechnology ETF made up ﹤0.01% of Polaris Financial Partners's portfolio in Q3 2026, its #297 holding.
  • 5 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Polaris Financial Partners's 13F filing for Q3 2026, filed 2 Oct 2026.